| Clonal history and genetic predictors of transformation into small-cell carcinomas from lung adenocarcinomas JK Lee, J Lee, S Kim, S Kim, J Youk, S Park, Y An, B Keam, DW Kim, ... Journal of clinical oncology 35 (26), 3065-3074, 2017 | 382 | 2017 |
| Association between expression level of PD1 by tumor-infiltrating CD8+ T cells and features of hepatocellular carcinoma HD Kim, GW Song, S Park, MK Jung, MH Kim, HJ Kang, C Yoo, K Yi, ... Gastroenterology 155 (6), 1936-1950. e17, 2018 | 245 | 2018 |
| Tracing oncogene rearrangements in the mutational history of lung adenocarcinoma JJK Lee, S Park, H Park, S Kim, J Lee, J Lee, J Youk, K Yi, Y An, IK Park, ... Cell 177 (7), 1842-1857. e21, 2019 | 172 | 2019 |
| Serotonin signals through a gut-liver axis to regulate hepatic steatosis W Choi, J Namkung, I Hwang, H Kim, A Lim, HJ Park, HW Lee, KH Han, ... Nature communications 9 (1), 4824, 2018 | 118 | 2018 |
| Clonal dynamics in early human embryogenesis inferred from somatic mutation S Park, NM Mali, R Kim, JW Choi, J Lee, J Lim, JM Park, JW Park, D Kim, ... Nature 597 (7876), 393-397, 2021 | 91 | 2021 |
| 4‐1BB Delineates Distinct Activation Status of Exhausted Tumor‐Infiltrating CD8+ T Cells in Hepatocellular Carcinoma HD Kim, S Park, S Jeong, YJ Lee, H Lee, CG Kim, KH Kim, SM Hong, ... Hepatology 71 (3), 955-971, 2020 | 81 | 2020 |
| Mutalisk: a web-based somatic MUTation AnaLyIS toolKit for genomic, transcriptional and epigenomic signatures J Lee, AJ Lee, JK Lee, J Park, Y Kwon, S Park, H Chun, YS Ju, D Hong Nucleic acids research 46 (W1), W102-W108, 2018 | 78 | 2018 |
| Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma JK Lee, S Louzada, Y An, SY Kim, S Kim, J Youk, S Park, SH Koo, ... Annals of Oncology 28 (4), 890-897, 2017 | 63 | 2017 |
| MET amplification, protein expression, and mutations in pulmonary adenocarcinoma S Park, J Koh, DW Kim, M Kim, B Keam, TM Kim, YK Jeon, DH Chung, ... Lung Cancer 90 (3), 381-387, 2015 | 60 | 2015 |
| VEGF and Ki-67 overexpression in predicting poor overall survival in adenoid cystic carcinoma S Park, SJ Nam, B Keam, TM Kim, YK Jeon, SH Lee, JH Hah, TK Kwon, ... Cancer Research and Treatment: Official Journal of Korean Cancer Association …, 2016 | 40 | 2016 |
| Nutritional status in the era of target therapy: poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutations S Park, S Park, SH Lee, B Suh, B Keam, TM Kim, DW Kim, YW Kim, ... The Korean journal of internal medicine 31 (6), 1140, 2016 | 38 | 2016 |
| 4-1BB co-stimulation further enhances anti-PD-1-mediated reinvigoration of exhausted CD39+ CD8 T cells from primary and metastatic sites of epithelial ovarian cancers G Leem, J Park, M Jeon, ES Kim, SW Kim, YJ Lee, SJ Choi, B Choi, ... Journal for immunotherapy of cancer 8 (2), 2020 | 37 | 2020 |
| Sox7 promotes high-grade glioma by increasing VEGFR2-mediated vascular abnormality IK Kim, K Kim, E Lee, DS Oh, CS Park, S Park, JM Yang, JH Kim, HS Kim, ... Journal of Experimental Medicine 215 (3), 963-983, 2018 | 37 | 2018 |
| Dll4 suppresses transcytosis for arterial blood-retinal barrier homeostasis JM Yang, CS Park, SH Kim, TW Noh, JH Kim, S Park, J Lee, JR Park, ... Circulation research 126 (6), 767-783, 2020 | 35 | 2020 |
| MK5 regulates YAP stability and is a molecular target in YAP-driven cancers J Seo, MH Kim, H Hong, H Cho, S Park, SK Kim, J Kim Cancer research 79 (24), 6139-6152, 2019 | 34 | 2019 |
| Pretreatment albumin-to-globulin ratio as a predictive marker for tyrosine kinase inhibitor in non-small cell lung cancer S Park, S Park, SH Lee, B Suh, CY Ock, B Keam, TM Kim, DW Kim, ... Cancer Biomarkers 16 (3), 425-433, 2016 | 25 | 2016 |
| Acquired resistance to third-generation EGFR tyrosine kinase inhibitors in patients with de novo EGFRT790M-mutant NSCLC HR Park, TM Kim, Y Lee, S Kim, S Park, YS Ju, M Kim, B Keam, YK Jeon, ... Journal of Thoracic Oncology 16 (11), 1859-1871, 2021 | 24 | 2021 |
| Implication of CD69+CD103+ tissue‐resident‐like CD8+ T cells as a potential immunotherapeutic target for cholangiocarcinoma HD Kim, S Jeong, S Park, YJ Lee, YS Ju, D Kim, GW Song, JH Lee, ... Liver International 41 (4), 764-776, 2021 | 22 | 2021 |
| The genome-wide landscape of C: G> T: A polymorphism at the CpG contexts in the human population J Youk, Y An, S Park, JK Lee, YS Ju BMC genomics 21, 1-11, 2020 | 21 | 2020 |
| Prospective evaluation of changes in tumor size and tumor metabolism in patients with advanced gastric cancer undergoing chemotherapy: association and clinical implication S Park, S Ha, HW Kwon, WH Kim, TY Kim, DY Oh, GJ Cheon, YJ Bang Journal of Nuclear Medicine 58 (6), 899-904, 2017 | 21 | 2017 |
